18 min

Diagnosis and Treatment of Interstitial Lung Disease JAMA Clinical Reviews

    • Medicine

Interstitial lung disease (ILD), characterized by inflammation and fibrosis of the lungs, is associated with progressive dyspnea and results in approximately 25 000 to 30 000 deaths in the US each year. Toby M. Maher, MD, MSc, PhD, of Keck Medicine of USC, discusses the diagnosis and management of ILD with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:
Interstitial Lung Disease

Interstitial lung disease (ILD), characterized by inflammation and fibrosis of the lungs, is associated with progressive dyspnea and results in approximately 25 000 to 30 000 deaths in the US each year. Toby M. Maher, MD, MSc, PhD, of Keck Medicine of USC, discusses the diagnosis and management of ILD with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:
Interstitial Lung Disease

18 min

More by JAMA Network

JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
Coronavirus (COVID-19) Q&A
JAMA Network
JAMA Network Open Conversations
JAMA Network
JAMAevidence Users' Guides to the Medical Literature
JAMA Network
JAMAevidence The Rational Clinical Examination
JAMA Network
JAMAevidence Care at the Close of Life
JAMA Network